Skip to Content

Join the 'Sacubitril / valsartan' group to help and get support from people like you.

Sacubitril / valsartan News

Know Your Heart's Numbers

Posted 7 Feb 2017 by

TUESDAY, Feb. 7, 2017 – More than two-thirds of Americans fret about heart disease, but few know the specific information that can help them boost their heart health, a new survey finds. "Studies have suggested the majority of coronary artery disease events can be prevented by addressing treatable risk factors," said Dr. Steve Nissen, chair of cardiovascular medicine at the Cleveland Clinic. ...

Statins Often Interact With Other Heart Drugs

Posted 17 Oct 2016 by

MONDAY, Oct. 17, 2016 – Cholesterol-lowering statins can interact with other drugs prescribed for heart disease. But there are ways to navigate the problem, according to new recommendations from the American Heart Association. Statins are among the mostly widely prescribed drugs in the United States. Roughly one-quarter of Americans age 40 and up are on a statin, according to a 2014 study by the ...

FDA Approves New Drug Entresto for Heart Failure

Posted 10 Jul 2015 by

THURSDAY, July 9, 2015 – The U.S. Food and Drug Administration has approved the first in a new class of drugs that show promise for combating heart failure. The approval of Entresto (sacubitril/varsatan) was sped up after a clinical trial found it significantly reduced the rate of death and hospitalization due to heart failure compared to another, often-prescribed treatment, the FDA said in a ...

Entresto Approved for Heart Failure

Posted 8 Jul 2015 by

TUESDAY, July 7, 2015 – The U.S. Food and Drug Administration on Tuesday approved the drug Entresto (sacubitril/valsartan) to treat heart failure. Characterized by the heart's inability to pump enough blood, the progressive disease affects some 5.1 million people in the United States. Heart attack, high blood pressure and other conditions that damage the heart are primary causes, the agency said ...

FDA Approves Entresto (sacubitril/valsartan) for Heart Failure

Posted 7 Jul 2015 by

July 7, 2015 – The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of cardiovascular death and hospitalization related to heart failure. Heart failure is a common condition affecting about 5.1 million people in the United States. It is a condition in which the heart can't pump ...

Ask a Question

Further Information

Related Condition Support Groups

Heart Failure, Congestive Heart Failure

Related Drug Support Groups


Sacubitril / valsartan Patient Information at